Publications by authors named "Teri E Klein"

Are you Teri E Klein?   Register this Author






Population-specific single-nucleotide polymorphism confers increased risk of venous thromboembolism in African Americans.
Mol Genet Genomic Med 2016 Sep 21;4(5):513-20. Epub 2016 Jun 21.
Department of GeneticsStanford University School of MedicineStanfordCalifornia94305; Department of BioengineeringStanford University School of MedicineStanfordCalifornia94305.

Developing knowledge resources to support precision medicine: principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
J Am Med Inform Assoc 2016 Jul 28;23(4):796-801. Epub 2016 Mar 28.
Departments of Medicine and Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.

PharmGKB summary: very important pharmacogene information for RYR1.
Pharmacogenet Genomics 2016 Mar;26(3):138-44
Departments of aGenetics bBioengineering, Stanford University, Stanford cChildren's Hospital Oakland Research Institute and UCSF, Oakland, California dDepartment of Medicine, University of North Dakota, Fargo, North Dakota eIMAGENETICS, Sanford Healthcare, Sioux Falls, South Dakota, USA.

PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics.
Pharmacogenet Genomics 2015 Dec;25(12):622-30
Departments of aGenetics bBioengineering, Stanford University, Stanford, California cDepartment of Anesthesiology dMoffitt Cancer Center, DeBartolo Family Personalized Medicine Institute, Tampa, Florida, USA eGenomics England, Queen Mary University of London, London, UK.

Sequence to Medical Phenotypes: A Framework for Interpretation of Human Whole Genome DNA Sequence Data.
PLoS Genet 2015 Oct 8;11(10):e1005496. Epub 2015 Oct 8.
Stanford Center for Inherited Cardiovascular Disease, Stanford University, Stanford, California, United States of America; Stanford Cardiovascular Institute, Stanford University, Stanford, California, United States of America; Division of Cardiovascular Medicine, Stanford University, Stanford, California, United States of America; Department of Genetics, Stanford University, Stanford, California, United States of America.

PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses.
Pharmacogenet Genomics 2015 Aug;25(8):416-26
aDepartment of Systems Pharmacology and Translational Therapeutics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Departments of bGenetics cBioengineering, Stanford University Medical Center, Stanford University, Stanford, California, USA.

Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs.
Mayo Clin Proc 2015 Jun;90(6):716-29
Center for Personalized Therapeutics, The University of Chicago, Chicago, IL; Department of Medicine, The University of Chicago, Chicago, IL; Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, IL. Electronic address:

PharmGKB summary: ibuprofen pathways.
Pharmacogenet Genomics 2015 Feb;25(2):96-106
aDepartment of Systems Pharmacology and Translational Therapeutics bInstitute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Departments of cGenetics dBioengineering, Stanford University, Stanford, California, USA.

Evidence synthesis and guideline development in genomic medicine: current status and future prospects.
Genet Med 2015 Jan 19;17(1):63-7. Epub 2014 Jun 19.
1] Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA [2] Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

PharmGKB summary: gemcitabine pathway.
Pharmacogenet Genomics 2014 Nov;24(11):564-74
Departments of aGenetics bBioengineering, Stanford University, Stanford, California, USA cDepartment of Pharmacotherapy and Translational Research dCenter for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, Florida eDepartment of Molecular Pharmacology & Experimental Therapeutics, Division of Clinical Pharmacology, Mayo Clinic, Rochester, Minnesota, USA.


PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics.
Pharmacogenet Genomics 2014 Sep;24(9):464-76
Departments of aGenetics bBioengineering, Stanford University, Stanford, California cACOS for Research, Department of Veterans Affairs Medical Center Departments of dMedicine ePharmacology/Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.
Pharmacogenet Genomics 2014 Aug;24(8):409-25
Departments of aGenetics bBioengineering, Stanford University, Palo Alto, California cDepartment of Pharmacology and Toxicology and James Graham Brown Cancer Center, University of Louisville, Kentucky, USA dDepartment of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece eDepartment of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden.

PharmGKB summary: tramadol pathway.
Pharmacogenet Genomics 2014 Jul;24(7):374-80
Departments of aGenetics bBioengineering, Stanford University, Stanford, California, USA cDepartment of Anaesthesiology and Pain Medicine, Inselspital dDepartment of Clinical Research, University of Bern, Bern, Switzerland eInstitute of Clinical Pharmacology, University Medical Center, Göttingen, Germany.

Clinical interpretation and implications of whole-genome sequencing.
JAMA 2014 Mar;311(10):1035-45
Stanford Center for Inherited Cardiovascular Disease, Stanford, California2Stanford Cardiovascular Institute, Stanford, California3Division of Cardiovascular Medicine, Stanford University, Stanford, California4Stanford Center for Genomics and Personalized.


PharmGKB summary: venlafaxine pathway.
Pharmacogenet Genomics 2014 Jan;24(1):62-72
Departments of aGenetics bBioengineering, Stanford University, Stanford, California, USA cInstitute of Pharmacology of Natural Products & Clinical Pharmacology, University of Ulm, Ulm dResearch Division, Federal Institute of Drugs & Medical Devices (BfArM), Bonn, Germany eDepartment of Pharmacology and Toxicology, Institute of Biomedicine, University of Oulu, Oulu, Finland.

PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8.
Pharmacogenet Genomics 2013 Dec;23(12):721-8
aDepartment of Pharmaceutical Sciences, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado Departments of bGenetics cBioengineering, Stanford University, Palo Alto, California, USA dDepartment of Clinical Pharmacology, University of Helsinki, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland.

PharmGKB summary: very important pharmacogene information for the epidermal growth factor receptor.
Pharmacogenet Genomics 2013 Nov;23(11):636-42
Departments of aGenetics bBioengineering, Stanford University Medical Center, Stanford, California, USA cBreakthrough Cancer Research Unit, Pangaea Biotech, Dexeus University Institute dMedical Oncology Service, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Barcelona, Spain.

PharmGKB summary: cyclosporine and tacrolimus pathways.
Pharmacogenet Genomics 2013 Oct;23(10):563-85
Departments of aGenetics bBioengineering, Stanford University, Stanford, California cDepartment of Pharmaceutical Sciences, School of Pharmacy dDepartment of Pathology, School of Medicine, Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA eSchool of Pharmacy, University of Queensland, Brisbane, Australia.

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.
Clin Pharmacol Ther 2013 Aug 19;94(2):207-10. Epub 2013 Mar 19.
Program in Personalized and Genomic Medicine and Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.


Nomenclature for alleles of the thiopurine methyltransferase gene.
Pharmacogenet Genomics 2013 Apr;23(4):242-8
Department of Medical and Health Sciences, Division of Drug Research, Faculty of Health Sciences, Linköping University, Linköping, Sweden.






PharmGKB summary: isoniazid pathway, pharmacokinetics.
Pharmacogenet Genomics 2016 09;26(9):436-44
Departments of aGenetics bBioengineering, Stanford University, Stanford cKeck School of Medicine of University of Southern California, Los Angeles, California, USA dDepartment of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece eDepartment of Pharmacology, University of Oxford, Oxford, UK.


PharmGKB summary: ivacaftor pathway, pharmacokinetics/pharmacodynamics.
Pharmacogenet Genomics 2017 01;27(1):39-42
Departments of aGenetics bBioengineering, Stanford University, Stanford, California cDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio, USA dGenomics England, Queen Mary University of London, London, UK.


PharmGKB summary: voriconazole pathway, pharmacokinetics.
Pharmacogenet Genomics 2017 05;27(5):201-209
Departments of aBiomedical Data Science bBioengineering, Stanford University, Stanford, California cIcahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine dDepartment of Medicine, Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai eDepartment of Pharmacy, The Mount Sinai Hospital, New York, New York, USA.


OF